Ducommun Inc
DCO
133.90
-5.31
-3.81%
Ducommun Inc
US · DCO
#2590 by market cap
Listed 1970
133.90
-5.31
-3.81%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.15, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Electronic Systems is the largest reported line at 57.09% of revenue, across 2 reported segments.
- Structural Systems follows at 42.91%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +4.88% YoY
Margins
- Gross margin
- 26.87%
- Operating margin
- 9.37%
- Net margin
- -4.12%
Key ratios & quality
- Enterprise valuei
- 2.29B
- Altman Z-Scorei
- 4.15
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 629.31M | 721.09M | 628.94M | 645.41M | 712.54M | 756.99M | 786.44M | 824.84M |
| Gross profit | 122.60M | 152.20M | 137.74M | 142.46M | 144.30M | 163.19M | 197.27M | 221.62M |
| Selling & admin expenses | 84.01M | 95.96M | 89.81M | 93.58M | 98.35M | 119.73M | 148.60M | 147.81M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 38.59M | 56.23M | 47.93M | 48.88M | 45.95M | 43.46M | 48.66M | 73.81M |
| Pretax profit | 10.27M | 37.76M | 31.98M | 170.48M | 33.32M | 16.38M | 26.92M | -47.25M |
| Tax | 1.24M | 5.30M | 2.81M | 34.95M | 4.53M | 451.00K | 5.24M | -9.89M |
| Net profit | 9.04M | 32.46M | 29.17M | 135.54M | 28.79M | 15.93M | 21.68M | -37.35M |
| Basic EPS | 1 | 3 | 3 | 11 | 2 | 1 | 1 | -3 |
| Diluted EPS | 0.77 | 2.75 | 2.45 | 11.06 | 2.33 | 1.14 | 1.44 | -2.50 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Revenue | 200.80M | 214.42M | 217.13M | 209.02M | 224.49M | 227.02M |
| Gross profit | 52.98M | 58.95M | 59.24M | 56.23M | 62.90M | 65.57M |
| Selling & admin expenses | 34.64M | 34.01M | 34.11M | 40.51M | 34.57M | 39.78M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 18.33M | 24.94M | 25.13M | 15.72M | 28.33M | 25.80M |
| Pretax profit | 16.46M | -78.24M | 12.82M | 11.71M | 24.81M | 18.84M |
| Tax | 3.71M | -17.42M | 3.51M | 1.79M | 4.41M | 4.95M |
| Net profit | 12.75M | -60.83M | 9.32M | 9.92M | 20.40M | 13.89M |
| Basic EPS | 1 | -4 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.84 | -4.06 | 0.48 | 0.64 | 1.31 | 0.89 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 284.08M | 340.77M | 410.28M | 492.57M | 527.34M | 549.57M | 568.09M | 625.98M |
| Cash & ST investments | 10.26M | 39.58M | 56.47M | 76.32M | 46.25M | 42.86M | 37.14M | 45.29M |
| Inventory | 101.13M | 112.48M | 129.22M | 150.94M | 171.21M | 199.20M | 196.99M | 182.79M |
| Total assets | 644.74M | 790.43M | 837.35M | 978.74M | 1.02B | 1.12B | 1.13B | 1.19B |
| Total current liabilities | 126.54M | 144.69M | 142.90M | 162.56M | 199.44M | 183.70M | 175.50M | 179.24M |
| Short-term debt | 2.33M | 9.96M | 10.13M | 13.13M | 13.41M | 15.69M | 21.03M | 12.82M |
| Long-term debt | 228.87M | 300.89M | 311.92M | 279.38M | 240.60M | 256.96M | 229.83M | 298.79M |
| Total liabilities | 387,914,000.00 | 497,629,000.00 | 508,013,000.00 | 504,133,000.00 | 495,546,000.00 | 484,825,000.00 | 446,151,000.00 | 524,934,000.00 |
| Total equity | 256.83M | 292.80M | 329.33M | 474.60M | 525.96M | 636.09M | 680.12M | 661.48M |
| Retained earnings | 180.36M | 212.55M | 241.73M | 377.26M | 406.05M | 421.98M | 443.66M | 406.30M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Total current assets | 598.24M | 681.35M | 625.98M | 633.86M | 661.44M | 706.51M |
| Cash & ST investments | 37.12M | 50.92M | 45.29M | 39.10M | 39.80M | 39.21M |
| Inventory | 197.30M | 192.82M | 182.79M | 186.27M | 191.71M | 195.76M |
| Total assets | 1.14B | 1.25B | 1.19B | 1.19B | 1.22B | 1.25B |
| Total current liabilities | 184.50M | 334.25M | 179.24M | 172.55M | 196.98M | 232.09M |
| Short-term debt | 21.37M | 20.30M | 12.82M | 12.01M | 11.72M | 11.84M |
| Long-term debt | 218.08M | 215.05M | 298.79M | 297.61M | 271.43M | 245.24M |
| Total liabilities | 433,000,000.00 | 599,525,000.00 | 524,934,000.00 | 515,537,000.00 | 534,116,000.00 | 541,272,000.00 |
| Total equity | 707.83M | 649.05M | 661.48M | 669.80M | 690.44M | 713.04M |
| Retained earnings | 476.54M | 412.09M | 406.30M | 416.22M | 436.62M | 450.51M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 46.24M | 51.03M | 12.61M | -565.00K | 32.68M | 31.07M | 34.18M | -33.41M |
| Depreciation & amortization | 25.30M | 28.31M | 28.85M | 28.39M | 31.42M | 32.57M | 33.44M | 33.66M |
| Free cash flow | 28.62M | 32.74M | 101.00K | -17.43M | 12.99M | 11.55M | 20.05M | -48.64M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | 85.11M | 0 | 0 |
| Ending cash balance | 10.26M | 39.58M | 56.47M | 76.32M | 46.25M | 42.86M | 37.14M | 45.29M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Operating cash flow | 22.41M | 18.10M | -74.69M | 11.24M | 33.55M | 32.68M |
| Depreciation & amortization | 8.27M | 8.34M | 8.46M | 8.24M | 8.55M | 8.34M |
| Free cash flow | 18.14M | 16.01M | -78.75M | 8.30M | 29.97M | 26.89M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 37.12M | 50.92M | 45.29M | 39.10M | 39.80M | 39.21M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.67 | 11.81 | 9.38 | 33.72 | 5.75 | 2.74 | 4.78 | -5.05 |
| ROA %i | 1.49 | 4.51 | 3.58 | 14.93 | 2.88 | 1.49 | 2.80 | -2.94 |
| ROIC %i | 4.36 | 8.70 | 6.47 | 19.77 | 4.84 | 4.15 | 4.72 | -2.46 |
| 5-year avg ROE %i | -0.09 | 0.66 | 9.31 | 13.51 | 12.87 | 12.68 | 10.98 | 7.99 |
| EBIT margin %i | 3.70 | 7.77 | 7.26 | 28.15 | 6.30 | 4.91 | 6.64 | -3.78 |
| FCF / sales %i | 4.55 | 4.54 | 0.02 | -- | 1.82 | 1.53 | 2.55 | -- |
| Current ratioi | 2.25 | 2.36 | 2.87 | 3.03 | 2.64 | 2.99 | 3.24 | 3.49 |
| Quick ratioi | 1.30 | 1.47 | 1.88 | 2.00 | 1.71 | 1.77 | 1.98 | 2.34 |
| Debt / assetsi | 35.86 | 41.55 | 40.20 | 32.76 | 27.69 | 26.37 | 24.16 | 29.15 |
| LT debt / equityi | 89.11 | 108.76 | 99.13 | 64.78 | 51.23 | 44.00 | 36.92 | 50.34 |
| Interest coveragei | 1.79 | 3.06 | 3.34 | 16.24 | 3.88 | 1.79 | 3.41 | -2.46 |
| Revenue CAGR (3Y) %i | -1.87 | 9.41 | 4.06 | 0.85 | -0.40 | 6.37 | 6.81 | 5.00 |
| Net income CAGR (3Y) %i | -- | 8.72 | 13.27 | 146.63 | -3.92 | -18.27 | -45.72 | -- |
| FCF CAGR (3Y) %i | 54.32 | 7.62 | -76.54 | -- | -26.52 | 385.32 | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| ROE %i | 5.86 | -5.27 | -5.05 | -3.73 | -2.54 | 8.36 |
| ROA %i | 3.52 | -2.91 | -2.94 | -2.20 | -1.50 | 4.55 |
| ROIC %i | 5.40 | -2.68 | -2.46 | -1.55 | -0.81 | 7.02 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.69 | -4.24 | -3.78 | -2.42 | -1.33 | 9.77 |
| FCF / sales %i | 5.11 | 5.54 | -- | -- | -- | -- |
| Current ratioi | 3.24 | 2.04 | 3.49 | 3.67 | 3.36 | 3.04 |
| Quick ratioi | 2.05 | 1.23 | 2.34 | 2.47 | 2.27 | 2.06 |
| Debt / assetsi | 22.47 | 21.74 | 29.15 | 28.91 | 27.34 | 24.46 |
| LT debt / equityi | 33.19 | 38.70 | 50.34 | 49.37 | 46.79 | 41.37 |
| Interest coveragei | 4.46 | -2.67 | -2.46 | -1.52 | -0.83 | 6.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Electronic Systems57.09%
Structural Systems42.91%
Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.
Ducommun Inc discussion 0 comments